Upregulated SMAD3 in Pancreatic Ductal AdenocarcinomaUpregulated SMAD3 in Pancreatic Ductal Adenocarcinoma

SMAD3 has been identified as gene related to the epithelial-mesenchymal transition. Might it serve as a biomarker of poor prognosis in pancreatic cancer? Laboratory Investigation
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news